Suppr超能文献

产后口服葡萄糖耐量试验的适应证。

Indications for the Postpartum Oral Glucose Tolerance Test.

机构信息

Diabetes Practice Cologne-East, Germany; winDiab GmbH, Kaarst, Germany; Antonius Hospital Cologne, Germany.

出版信息

Dtsch Arztebl Int. 2024 Apr 19;121(8):251-257. doi: 10.3238/arztebl.m2024.0034.

Abstract

BACKGROUND

Gestational diabetes mellitus (GDM) affects more than 50 000 pregnant women in Germany every year. In postpartum diabetes screening, a 75 g oral glucose tolerance test (OGT) is recommended. This is time-consuming and can have side effects, and only 40% of mothers take it. The determination of pre-test probabilities might obviate the need for OGT except in women who are at particular risk.

METHODS

We analyzed 5444 cases of GDM from the GestDiab registry over the period 2015-2019. The pretest probabilities of a postpartum diagnosis of diabetes mellitus (DM) or prediabetes were calculated on the basis of clinical variables including postpartum venous fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c).

RESULTS

In 0.77% of mothers with a history of GDM in whom DM was not detected by FPG or HbA1c, postpartum DM was diagnosed on the basis of the 2-hour value in the OGT. Individual estimation of the pre-test probability of a diagnosis by OGT of postpartum DM or prediabetes was possible with the aid of the FPG and HbA1c values and clinical predictors including insulin treatment during pregnancy, obesity, GDM diagnosed before 24 weeks of gestation, age over 35, and a 1-hour value in the diagnostic OGT during pregnancy of 180 mg/dL (10.0 mmol/L) or above. The pretest probability of postpartum DM in the study group ranged from 0.11% to 4.17%, and that of postpartum prediabetes from 6.4% to 16.3%.

CONCLUSION

The probability of a diagnosis of postpartum diabetes by OGT after GDM can be estimated in postpartum screening on the basis of various parameters. This enables risk-adapted counseling of the affected women along with a long-term strategy for diabetes prevention and follow-up. The findings of our study should be verified by further research.

摘要

背景

每年德国有超过 50000 名孕妇患有妊娠期糖尿病(GDM)。在产后糖尿病筛查中,推荐进行 75g 口服葡萄糖耐量试验(OGT)。但该检测耗时且可能有副作用,只有 40%的产妇会进行检测。如果能够确定产前患病概率,除了那些高风险的产妇,可能就无需进行 OGT 检测了。

方法

我们分析了 2015 年至 2019 年期间,来自 GestDiab 注册研究的 5444 例 GDM 病例。基于包括产后静脉空腹血糖(FPG)和糖化血红蛋白(HbA1c)在内的临床变量,计算了产后发生糖尿病(DM)或糖尿病前期的患病概率。

结果

在产后 FPG 或 HbA1c 未检出 DM 的 GDM 产妇中,有 0.77%的产妇在 OGT 2 小时检测时被诊断为产后 DM。借助 FPG 和 HbA1c 值以及包括孕期胰岛素治疗、肥胖、24 周前诊断的 GDM、年龄超过 35 岁以及妊娠时诊断性 OGT 的 1 小时值为 180mg/dL(10.0mmol/L)或更高在内的临床预测因素,可对 OGT 检测诊断产后 DM 或糖尿病前期的个体患病概率进行评估。在研究组中,产后 DM 的患病概率从 0.11%到 4.17%不等,产后糖尿病前期的患病概率从 6.4%到 16.3%不等。

结论

可以根据各种参数在产后筛查中对 GDM 后 OGT 检测诊断产后糖尿病的概率进行估计。这使我们能够对受影响的女性进行风险适应性咨询,并制定长期的糖尿病预防和随访策略。我们的研究结果应通过进一步的研究加以验证。

相似文献

1
Indications for the Postpartum Oral Glucose Tolerance Test.产后口服葡萄糖耐量试验的适应证。
Dtsch Arztebl Int. 2024 Apr 19;121(8):251-257. doi: 10.3238/arztebl.m2024.0034.
4
HbA1c for diagnosis and prognosis of gestational diabetes mellitus.糖化血红蛋白用于妊娠期糖尿病的诊断和预后评估。
Diabetes Res Clin Pract. 2015 Oct;110(1):38-43. doi: 10.1016/j.diabres.2015.07.014. Epub 2015 Aug 13.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验